Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
FDA Inspection
•Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services•June 10, 2026

Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services – FDA Inspection, Jun 10, 2026

Record Details

This FDA Inspection record concerns Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services, with an inspection on June 10, 2026, issued by the New England District Office, covering human drugs.

Company
Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
Inspection Date
June 10, 2026
Product Type
Human Drugs
Office
New England District Office
People
  • Armen H. Youssoufian (Issuing Officer)
  • Daniel L. Zheng (FDA Associated Person)
  • Ogechi C. Nna (Investigator)
  • Talia A. Faison (Issuing Officer)
  • Wayne E. Seifert (Senior Regulatory Specialist)
View Company Profile

ID · 98be2869-e2d8-4d6d-8f31-f8b092a80149

Inspection Facts

Inspection number
1321518
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

6
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.113(b)Procedures for sterile drug products
  3. 21 CFR 211.192Investigations of discrepancies, failures
  4. 21 CFR 211.58Buildings not maintained in good state of repair
  5. 21 CFR 211.63Equipment Design, Size and Location
  6. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services

8
DateClassificationOfficeProject area
May 24, 2024VAICenter for Drug Evaluation and ResearchNew Drug Evaluation
September 27, 2023OAINew England District Office
December 7, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 15, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 15, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
  • FDA Inspection 1239754 - 2024-05-24
  • FDA Inspection 1218916 - 2023-09-27
  • FDA Inspection 1074079 - 2018-12-07
  • FDA Inspection 1003136 - 2017-02-15
  • FDA Inspection 1002975 - 2017-02-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.